Skip to content

Effects of Isolated LBBB on Maximal Functional Capacity

Effects of Isolated Left Bundle Branch Block on Maximal Functional Capacity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05643404
Enrollment
162
Registered
2022-12-08
Start date
2022-12-22
Completion date
2024-07-09
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Left Bundle-Branch Block

Keywords

Functional capacity, Cardiac dyssynchrony, Myocardial deformation

Brief summary

Left bundle branch block (LBBB) has been commonly associated with adverse cardiovascular (CV) events, but the effect of an isolated LBBB on maximal functional capacity is not well characterized. The study's main objective is to evaluate the effect of LBBB on maximum functional capacity.

Detailed description

Left bundle branch block (LBBB) has been commonly associated with adverse cardiovascular (CV) events, but the effect of an isolated LBBB on maximal functional capacity is not well characterized. The main objective of the study is to evaluate the effect of LBBB on maximum functional capacity (objectively evaluated by the maximum oxygen consumption -VO2max- at peak exercise in a cardiopulmonary stress test -CPET-) in subjects with LBBB without known cardiovascular disease and compare these data with controls without LBBB. This is a prospective study that will be carried out in a single centre. All patients with a diagnosis of LBBB and without evidence of structural heart disease in imaging tests will be enrolled. For each candidate with LBBB, one control without LBBB and matched for age, sex, body surface area, and daily physical activity will be selected. All included subjects will undergo a CPET and echocardiography. A sample size estimation \[alpha: 0.05, power: 80%, and a clinically significant VO2max difference between groups of at least 10%\] of 148 subjects (74 subjects with LBBB + 74 controls) would be necessary to test our hypothesis.

Interventions

DIAGNOSTIC_TESTCardiopulmonary exercise testing

Maximal functional capacity will be evaluated using incremental and symptom-limited cardiopulmonary exercise testing (CPET) on a bicycle ergometer, beginning with a workload of 10 W and increasing gradually in a ramp protocol at 10-W increments every 1 minute. We will define maximal functional capacity as when the patient stops pedalling because of symptoms, and the respiratory exchange ratio (RER) is ≥1.1. During exercise, patients were monitored with 12-lead electrocardiogram and blood pressure measurements every 2 minutes. Gas exchange data and cardiopulmonary variables were averages of values taken every 10 seconds. Peak oxygen consumption (PeakVO2) will be defined as the highest value of oxygen consumption during the last 20 seconds of exercise.

DIAGNOSTIC_TESTEchocardioghaphy

Doppler echocardiogram examinations were performed under resting conditions using 2-dimensional echocardiography. Left ventricular end-diastolic volume and left ventricular ejection fraction will be measured according to the European Society of Echocardiography

Sponsors

Fundación para la Investigación del Hospital Clínico de Valencia
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult \>18 years old * ECG criteria of left bundle branch block (for controls without left bundle branch block ) * Provide informed consent

Exclusion criteria

* Inability to perform a maximal baseline exercise test; * Structural heart disease, valve heart disease or diastolic dysfunction estimated by two-dimensional echocardiography; * Previous ischemic heart disease, heart failure, myocardiopathy or myocarditis * Effort angina during cardiopulmonary exercise testing (CPET); * Any moderate pulmonary disease; * Anaemia * Left ventricular ejection fraction \< 55%.

Design outcomes

Primary

MeasureTime frameDescription
Peak oxygen consumptionEligible patients will perform only one cardiopulmonary exercise testing on the first visit. Peak oxygen consumption will be evaluated during the procedure and compared to control patients.Peak oxygen consumption at peak exercise of a maximal symptom-limited cardiopulmonary exercise testing. Units peak oxygen consumption : mL/kg/min

Secondary

MeasureTime frameDescription
Left ventricular end-diastolic volumeEligible patients will perform only one echocardiography on the first visit. Left ventricular end-diastolic volume will be assessed during the procedure and compared to control patients.Evaluate left ventricular end-diastolic indexed volume by echocardiography at rest. Unit: ml/m2
Left ventricular ejection fractionEligible patients will perform only one echocardiography on the first visit. Left ventricular ejection fraction will be assessed during the procedure and compared to control patients.Evaluate left ventricular ejection fraction by echocardiography at rest. Unit: %

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026